학술논문

Cost-effectiveness of the recombinant zoster vaccine in the German population aged >= 60 years old
Document Type
Journal
Source
HUMAN VACCINES & IMMUNOTHERAPEUTICS; JAN 2 2019, 15 1, p34-p44, 11p.
Subject
Language
English
ISSN
2164554X